CN116687781A - Composition for enhancing mitochondrial energy and application thereof - Google Patents
Composition for enhancing mitochondrial energy and application thereof Download PDFInfo
- Publication number
- CN116687781A CN116687781A CN202310830062.4A CN202310830062A CN116687781A CN 116687781 A CN116687781 A CN 116687781A CN 202310830062 A CN202310830062 A CN 202310830062A CN 116687781 A CN116687781 A CN 116687781A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- skin
- mitochondrial energy
- enhancing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 230000002438 mitochondrial effect Effects 0.000 title claims abstract description 52
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 51
- 102000008186 Collagen Human genes 0.000 claims abstract description 21
- 108010035532 Collagen Proteins 0.000 claims abstract description 21
- 229920001436 collagen Polymers 0.000 claims abstract description 21
- 239000006071 cream Substances 0.000 claims description 72
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 46
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 36
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 24
- 229940041290 mannose Drugs 0.000 claims description 24
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 23
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 23
- 229960005305 adenosine Drugs 0.000 claims description 23
- 229940083542 sodium Drugs 0.000 claims description 23
- 239000011734 sodium Substances 0.000 claims description 23
- 229910052708 sodium Inorganic materials 0.000 claims description 23
- NDVRKEKNSBMTAX-MVNLRXSJSA-N (2s,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O NDVRKEKNSBMTAX-MVNLRXSJSA-N 0.000 claims description 21
- -1 alkyl glucoside Chemical class 0.000 claims description 21
- 239000003963 antioxidant agent Substances 0.000 claims description 21
- 235000006708 antioxidants Nutrition 0.000 claims description 21
- 239000003906 humectant Substances 0.000 claims description 21
- 230000003078 antioxidant effect Effects 0.000 claims description 20
- 239000000499 gel Substances 0.000 claims description 19
- 229940041514 candida albicans extract Drugs 0.000 claims description 18
- 229960003624 creatine Drugs 0.000 claims description 18
- 239000006046 creatine Substances 0.000 claims description 18
- 239000012138 yeast extract Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 235000007164 Oryza sativa Nutrition 0.000 claims description 15
- 238000000855 fermentation Methods 0.000 claims description 14
- 230000004151 fermentation Effects 0.000 claims description 14
- 235000009566 rice Nutrition 0.000 claims description 14
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 13
- 150000004676 glycans Chemical class 0.000 claims description 13
- 229920001282 polysaccharide Polymers 0.000 claims description 13
- 239000005017 polysaccharide Substances 0.000 claims description 13
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 12
- LODWEXDBRZBADB-XEVVZDEMSA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-methylbutanoyl]amino]hexanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O LODWEXDBRZBADB-XEVVZDEMSA-N 0.000 claims description 12
- KOGFZZYPPGQZFZ-QVAPDBTGSA-N (2s,3r,4s,5r)-2-(2-hydroxypropyl)oxane-3,4,5-triol Chemical compound CC(O)C[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O KOGFZZYPPGQZFZ-QVAPDBTGSA-N 0.000 claims description 12
- QZLXCFQVOCEKSX-NOCHOARKSA-N (2s,4r)-1-hexadecanoyl-4-hexadecanoyloxypyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H]1C[C@@H](C(O)=O)N(C(=O)CCCCCCCCCCCCCCC)C1 QZLXCFQVOCEKSX-NOCHOARKSA-N 0.000 claims description 12
- 241000186660 Lactobacillus Species 0.000 claims description 12
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 12
- 241001506047 Tremella Species 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 12
- 229920002674 hyaluronan Polymers 0.000 claims description 12
- 229960003160 hyaluronic acid Drugs 0.000 claims description 12
- 229940039696 lactobacillus Drugs 0.000 claims description 12
- 229940094912 palmitoyl tripeptide-5 Drugs 0.000 claims description 12
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 12
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 12
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 10
- 239000003995 emulsifying agent Substances 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 239000002562 thickening agent Substances 0.000 claims description 10
- JRKXPOFVUIWSJO-UHFFFAOYSA-N FC(C(=O)O)(F)F.NC(=O)N.NC(C(=O)O)CC Chemical compound FC(C(=O)O)(F)F.NC(=O)N.NC(C(=O)O)CC JRKXPOFVUIWSJO-UHFFFAOYSA-N 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 230000003750 conditioning effect Effects 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 235000019198 oils Nutrition 0.000 claims description 8
- 229940113120 dipropylene glycol Drugs 0.000 claims description 7
- 239000003607 modifier Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 4
- 239000003205 fragrance Substances 0.000 claims description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- USIVMVHZRCKJGX-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;urea Chemical compound NC(N)=O.OC(=O)C(F)(F)F USIVMVHZRCKJGX-UHFFFAOYSA-N 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 2
- 229920002498 Beta-glucan Polymers 0.000 claims description 2
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 2
- 241000207199 Citrus Species 0.000 claims description 2
- 240000002319 Citrus sinensis Species 0.000 claims description 2
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- 229920002367 Polyisobutene Polymers 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 244000044822 Simmondsia californica Species 0.000 claims description 2
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 2
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 claims description 2
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 2
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 claims description 2
- 229960000541 cetyl alcohol Drugs 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 239000001599 crocus sativus l. flower extract Substances 0.000 claims description 2
- 229920006037 cross link polymer Polymers 0.000 claims description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000006166 lysate Substances 0.000 claims description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 229940060184 oil ingredients Drugs 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- 229940101267 panthenol Drugs 0.000 claims description 2
- 235000020957 pantothenol Nutrition 0.000 claims description 2
- 239000011619 pantothenol Substances 0.000 claims description 2
- 229940068065 phytosterols Drugs 0.000 claims description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 2
- 229940108325 retinyl palmitate Drugs 0.000 claims description 2
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 2
- 239000011769 retinyl palmitate Substances 0.000 claims description 2
- 229940109850 royal jelly Drugs 0.000 claims description 2
- 229940076591 saffron extract Drugs 0.000 claims description 2
- 229940032094 squalane Drugs 0.000 claims description 2
- 229940104261 taurate Drugs 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims 1
- 230000001815 facial effect Effects 0.000 claims 1
- 229940001941 soy protein Drugs 0.000 claims 1
- 230000009759 skin aging Effects 0.000 abstract description 9
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 230000002195 synergetic effect Effects 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 230000003851 biochemical process Effects 0.000 abstract description 3
- 230000010001 cellular homeostasis Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 58
- 238000012360 testing method Methods 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 23
- 230000000694 effects Effects 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 102000016942 Elastin Human genes 0.000 description 15
- 108010014258 Elastin Proteins 0.000 description 15
- 229920002549 elastin Polymers 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 13
- 239000000523 sample Substances 0.000 description 12
- 230000037303 wrinkles Effects 0.000 description 12
- 241000209094 Oryza Species 0.000 description 11
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 8
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 6
- 206010018910 Haemolysis Diseases 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000008588 hemolysis Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000004927 skin cell Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- 230000004900 autophagic degradation Effects 0.000 description 3
- 230000007760 free radical scavenging Effects 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000001575 punica granatum l. bark extract Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 230000037067 skin hydration Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 229940111782 egg extract Drugs 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 102000004121 Annexin A5 Human genes 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 240000009108 Chlorella vulgaris Species 0.000 description 1
- 235000007089 Chlorella vulgaris Nutrition 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- OSYWFNIZAFNPSR-UHFFFAOYSA-N FC(C(=O)O)(F)F.NC(=O)N.C(CCC)(=O)O Chemical compound FC(C(=O)O)(F)F.NC(=O)N.C(CCC)(=O)O OSYWFNIZAFNPSR-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 240000000894 Lupinus albus Species 0.000 description 1
- 235000010649 Lupinus albus Nutrition 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229940083913 c14-22 alcohols Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027829 mitochondrial depolarization Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention provides a composition for enhancing mitochondrial energy and application thereof. The composition for enhancing mitochondrial energy has reasonable compatibility of the components, has a synergistic effect, can provide substances and energy for biochemical processes, can improve the self-oxidation resistance of skin, maintain cell homeostasis, promote collagen synthesis and obviously improve skin aging.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a composition for enhancing mitochondrial energy and application thereof.
Background
Aging is an inevitable natural law in the life process, and is generally considered to be the result of the combined action of various factors including exogenous environmental stimulus, endogenous gene attenuation and the like. The main expression of endogenous gene attenuation is that with the progressive increase of AGEs, collagen forms intermolecular crosslinking, so that not only the elasticity and permeability of skin are reduced, and the diffusion performance of nutrients and wastes is weakened, but also the solubility of collagen is reduced, so that collagen is difficult to hydrolyze by collagenase, the elasticity of skin is reduced, wrinkles are difficult to smooth and deepen continuously, and the aging process of skin is accelerated, so that skin care products with metabolism built on skin surface cells are increasingly favored by people.
CN108245450a discloses a complex containing extract of pomegranate peel and its application. The composite containing the pomegranate peel extract comprises the pomegranate peel extract and glacier water, wherein the ratio of the pomegranate peel extract to the glacier water is 2-100 g/L. The compound disclosed by the compound has the capability of scavenging free radicals and improving autophagy capability of cells, achieves the effects of enhancing the antioxidant capability of skin and scavenging skin metabolic wastes so as to delay aging and whiten skin, and can be used as an efficacy additive to be added into cosmetics.
CN113413398A discloses a fish egg extract and its application. The fresh water roe extract, the stock solution of the sea water roe extract and different components provided by the fresh water roe extract have DPPH free radical scavenging activity, which indicates that the roe extract has a certain degree of in vitro antioxidation. The roe extract can inhibit proliferation of breast cancer cells MCF7, induce apoptosis of MCF7 cells, such as morphological change of apoptosis, positive expression of Annexin V/PI, etc.; the production of reactive oxygen species and superoxide within MCF7 cells and mitochondrial depolarization were seen 24h after fish egg extract treatment of the cells.
However, the above products do not take into account barrier repair and immune enhancement of aging fragile skin, and do not achieve an ideal health state. Based on this, it is necessary to develop a skin care product with multiple functions to meet the requirements of modern people.
Disclosure of Invention
In view of the shortcomings of the prior art, it is an object of the present invention to provide a composition for enhancing mitochondrial energy and its use.
In order to achieve the aim of the invention, the invention adopts the following technical scheme:
in a first aspect, the present invention provides a composition for enhancing mitochondrial energy comprising adenosine, sodium mannose phosphate, and mannose.
The adenosine in the composition provided by the invention is an important intermediate for synthesizing Adenosine Triphosphate (ATP), and ATP can improve the metabolic capacity of an organism and slow down aging; the sodium mannose phosphate is a key to initiate lysosomal autophagy, which can be used to promote differentiation of human fat-derived stem cells; the mannose and the adenosine and the mannose sodium phosphate are matched to promote the functional components to penetrate through skin barriers to enter deep skin tissues, increase the functional components to enter mitochondria, further enhance the energy of the mitochondria, improve the autophagy capacity of cells, promote the synthesis of collagen and elastin, and have synergistic interaction, so that substances and energy can be provided for biochemical processes, the self antioxidant capacity of skin can be improved, the cell homeostasis is maintained, the synthesis of collagen is promoted, and the skin aging condition is obviously improved.
Preferably, the mass ratio of the adenosine to the sodium mannose phosphate to the mannose is (3-5): 1-3): 1-2.
Preferably, the composition for enhancing mitochondrial energy further comprises creatine and/or yeast extract.
Preferably, the composition for enhancing mitochondrial energy comprises adenosine, sodium mannose phosphate, mannose, creatine and yeast extract.
As a preferable technical scheme of the invention, the creatine can store and transfer energy for skin cells, is an important source of skin energy, and can stimulate the biological activity of the skin cells in the transformation of DNA synthesis bodies of the skin cells and the repair of DNA, so as to continue skin aging; the yeast extract contains various small molecular amino acids and polysaccharides, has the advantages of rich nutrition, small molecular weight, easy absorption, comprehensive efficacy and the like, can specifically support the self protection of skin, has various effects of delaying skin aging, moisturizing, improving skin quality, tightening, removing wrinkles and the like, and can further improve the effects of enhancing cell energy and delaying skin aging by adding creatine and the yeast extract.
Preferably, the mass ratio of adenosine, sodium mannose phosphate, mannose, creatine and yeast extract is (3-5): 1-3): 1-2): 3-5): 0.1-1.
Wherein the first "3-5" may be 3.2, 3.4, 3.5, 3.7, 3.9, 4, 4.2, 4.5, 4.7, 4.9, etc.;
"1-3" may be 1.2, 1.4, 1.5, 1.6, 1.8, 2, 2.2, 2.4, 2.5, 2.6, 2.8, etc.;
"1-2" may be 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, etc.;
the second "3-5" may be 3.2, 3.4, 3.5, 3.7, 3.9, 4, 4.2, 4.5, 4.7, 4.9, etc.;
"0.1-1" may be 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, etc.
Specific point values in the numerical ranges are selectable, and will not be described in detail here.
In a second aspect, the present invention provides the use of a composition for enhancing mitochondrial energy according to the first aspect in cosmetics.
Preferably, the cosmetic comprises a cream, lotion, emulsion, face cream or mask.
Preferably, the composition for enhancing mitochondrial energy is 1-15% by mass in the cosmetic, for example, may be 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13% or 14%, etc., and specific values in the above numerical ranges are selected, and will not be described in detail herein.
In a third aspect, the present invention provides a skin-lightening anti-wrinkle essence cream comprising a mitochondrial energy enhancing composition as described in the first aspect, a humectant, a thickener, a skin conditioner, an antioxidant, an emulsifier, a skin feel modifier and deionized water.
The gel Yan Kangzhou essence cream disclosed by the invention can provide more nutrition and energy for skin cells through the combination of the composition for enhancing mitochondrial energy and components such as a humectant, an antioxidant and a skin conditioner, so that the cream has a better effect of delaying skin aging and can also have a better effect of resisting saccharification, deeply moisturizing skin and tightening skin.
Preferably, the gel Yan Kangzhou essence cream comprises, by weight, 1-15 parts of the composition for enhancing mitochondrial energy according to the first aspect, 1-20 parts of a humectant, 0.1-1 part of a thickener, 5-10 parts of a skin conditioner, 0.1-1 part of an antioxidant, 1-10 parts of an emulsifier, 1-10 parts of a skin feel modifier and 1-90 parts of deionized water.
The composition for enhancing mitochondrial energy in the gel Yan Kangzhou essence cream of the invention can be added in an amount of 2 parts, 4 parts, 5 parts, 6 parts, 8 parts, 10 parts, 12 parts or 14 parts, etc.;
the humectant can be added in an amount of 1 part, 3 parts, 5 parts, 7 parts, 9 parts, 10 parts, 12 parts, 15 parts, 17 parts, 19 parts, or the like;
the thickener may be added in an amount of 0.2 parts, 0.3 parts, 0.4 parts, 0.5 parts, 0.6 parts, 0.7 parts, 0.8 parts, 0.9 parts, or the like;
the skin conditioning agent may be added in an amount of 5.5 parts, 6 parts, 6.5 parts, 7 parts, 7.5 parts, 8 parts, 8.5 parts, 9 parts, 9.5 parts, or the like;
the antioxidant may be added in an amount of 0.2 parts, 0.3 parts, 0.4 parts, 0.5 parts, 0.6 parts, 0.7 parts, 0.8 parts, or 0.9 parts, etc.;
the addition amount of the emulsifier can be 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts, 8 parts or 9 parts, etc.;
the addition amount of the skin feel modifier can be 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts, 8 parts or 9 parts, etc.;
the deionized water may be added in an amount of 5 parts, 10 parts, 20 parts, 30 parts, 40 parts, 50 parts, 60 parts, 70 parts, 80 parts, 90 parts, or the like.
Preferably, the humectant comprises any one or a combination of at least two of glycerin, butylene glycol, panthenol, hyaluronic acid, sodium hyaluronate, dipropylene glycol or tremella polysaccharide.
Preferably, the humectant is a combination of butylene glycol, dipropylene glycol, hyaluronic acid, sodium hyaluronate, and tremella polysaccharide.
In the invention, when the humectant is the combination of butanediol, dipropylene glycol, hyaluronic acid, sodium hyaluronate and tremella polysaccharide, the moisturizing effect of the essence cream can be further improved, and the butanediol, dipropylene glycol, hyaluronic acid, sodium hyaluronate and tremella polysaccharide also have a certain synergistic effect on the effects.
Preferably, the thickener comprises any one or a combination of at least two of acrylic acid (esters) and C10-30 alkanol acrylate cross-linked polymers, cetyl alcohol or stearyl alcohol.
Preferably, the antioxidant comprises any one or a combination of at least two of retinol palmitate, p-hydroxyacetophenone or tocopheryl acetate.
Preferably, the emulsifier comprises any one or a combination of at least two of hydrogenated lecithin, phytosterols, C14-22 alcohols/C12-20 alkyl glucosides or ammonium acryloyldimethyl taurate/VP copolymer.
Preferably, the skin feel modifier comprises any one or a combination of at least two of sodium polyacryl dimethyl taurate, polyisobutylene, PEG-7 trimethylol propyl coco ether, cetyl ethyl hexanoate, diisostearyl malate, polydimethylsiloxane, rice (ORYZA SATIVA) germ oil, aluminum starch octenyl succinate, squalane, or jojoba seed oil.
Preferably, the skin conditioning agent comprises any one or a combination of at least two of soluble collagen, lactobacillus/rice fermentation product, dipalmitoyl hydroxyproline, dipotassium glycyrrhizinate, nicotinamide, beta-glucan, hydroxypropyl tetrahydropyran triol, palmitoyl tripeptide-5, yeast lysate, citrus (CITRUS RETICULATA) pericarp extract, chlorella (CHLORELLA VULGARIS)/Bai Yushan bean (LUPINUS ALBUS) protein fermentation product, hydrolyzed royal jelly protein, tetradecylamino Ding Xianxie amino amidobutyric acid urea trifluoroacetate, soluble collagen, saffron extract or sweet orange extract.
Preferably, the skin conditioning agent is a combination of niacinamide, lactobacillus/rice fermentation product, dipalmitoyl hydroxyproline, hydroxypropyl tetrahydropyran triol, palmitoyl tripeptide-5, soluble collagen and tetradecylamino Ding Xianxie amino butyric acid urea trifluoroacetate.
In the invention, the skin conditioner is the combination of nicotinamide, lactobacillus/rice fermentation product, dipalmitoyl hydroxyproline, hydroxypropyl tetrahydropyran triol, palmitoyl tripeptide-5, soluble collagen and tetradecylamino Ding Xianxie amino carbamide butyrate urea trifluoroacetate, so that the antioxidant and anti-saccharification effects of the essence cream can be further enhanced.
Preferably, the gel Yan Kangzhou essence cream further comprises any one or a combination of at least two of a pH regulator, a preservative or a fragrance.
In a fourth aspect, the present invention provides a method for preparing the essence cream of gel Yan Kangzhou according to the third aspect, which comprises the following steps:
(1) Adding deionized water, a humectant and a thickener into a water phase pot, stirring, heating and preserving heat; adding the emulsifier, the skin feel regulator and the antioxidant into an oil phase pot, stirring, heating and preserving heat;
(2) After the heat preservation is finished, pumping water and an oil pot into an emulsifying pot, homogenizing, stirring and cooling under vacuum, adding the composition for enhancing mitochondrial energy and the skin conditioning agent according to the first aspect, and uniformly mixing to obtain the product.
Preferably, the temperature of the incubation in step (1) is 80-85 ℃ (e.g. 81 ℃, 82 ℃, 83 ℃, 84 ℃ or 85 ℃ and the like) and the time of the incubation is 10-20min (11 min, 13min, 15min, 17min or 19min and the like) respectively.
Preferably, the temperature of the homogenization in the step (2) is 60-70 ℃ (for example, 61 ℃, 62 ℃, 63 ℃, 64 ℃, 65 ℃, 66 ℃, 67 ℃, 68 ℃ or 69 ℃ and the like), the time of the homogenization is 5-10min (for example, 6min, 7min, 8min, 9min or 10min and the like), and the rotation speed of the homogenization is 500-1000rpm (for example, 600rpm, 700rpm, 800rpm, 900rpm or 1000rpm and the like).
Preferably, the temperature of the step (2) is reduced to 30-40deg.C (such as 31deg.C, 32deg.C, 33deg.C, 34 deg.C, 35deg.C, 36deg.C, 37deg.C, 38deg.C or 39deg.C).
Preferably, step (2) further comprises adding any one or a combination of at least two of a pH adjuster, a fragrance, or a preservative.
Specific point values in the numerical ranges are selectable, and will not be described in detail here.
Compared with the prior art, the invention has the following beneficial effects:
(1) The composition for enhancing mitochondrial energy has reasonable compatibility of the components, has a synergistic effect, can provide substances and energy for biochemical processes, can improve the self-oxidation resistance of skin, maintain cell homeostasis, promote collagen synthesis and obviously improve skin aging.
(2) The gel Yan Kangzhou essence cream disclosed by the invention can provide more nutrition and energy for skin cells through the combination of the composition for enhancing mitochondrial energy and components such as a humectant, an antioxidant and a skin conditioner, so that the cream has a better effect of delaying skin aging and can also have a better effect of resisting saccharification, deeply moisturizing skin and tightening skin.
Detailed Description
In order to further describe the technical means adopted by the present invention and the effects thereof, the following describes the technical scheme of the present invention in combination with the preferred embodiments of the present invention, but the present invention is not limited to the scope of the embodiments.
The adenosine in the embodiment of the invention is purchased from Nanjing Seebeck biotechnology Co., ltd;
the mannose sodium phosphate is purchased from Beijing Yan Zhishan technology Co., ltd;
the mannose is purchased from Beijing yangshan science and technology Co;
the creatine was purchased from AlzChem Trostberg GmbH;
the yeast extract was purchased from Angel Yeast Co.
The remaining materials can be used as long as they are purchased from a regular dealer.
The adenosine, sodium mannose phosphate, mannose, creatine and yeast extract, which are described below, are all calculated by the actual content of the functional components contained in the commercial raw materials, and any one or a combination of at least two of solvents, fillers, diluents, stabilizers, pH regulators, antibacterial agents, antioxidants and impurities within the allowable range may be optionally contained in the commercial raw materials.
Example 1
This example provides a composition for enhancing mitochondrial energy comprising 2 parts adenosine, 1 part sodium mannose phosphate, 0.75 part mannose, 2 parts creatine and 0.25 part yeast extract.
Example 2
This example provides a composition for enhancing mitochondrial energy comprising 2.5 parts adenosine, 0.5 parts sodium mannose phosphate, 1 part mannose, 1.5 parts creatine and 0.5 parts yeast extract.
Example 3
This example provides a composition for enhancing mitochondrial energy comprising 1.5 parts adenosine, 1.5 parts sodium mannose phosphate, 0.5 parts mannose, 2.5 parts creatine and 0.2 parts yeast extract.
Example 4
This example provides a composition for enhancing mitochondrial energy that differs from example 1 only in that creatine is not included, its reduced amount is added to the yeast extract, and the remaining components and amounts added are unchanged.
Example 5
This example provides a composition for enhancing mitochondrial energy that differs from example 1 only in that the yeast extract is not included, its reduced amount is added to creatine, and the remaining components and amounts added are unchanged.
Example 6
This example provides a composition for enhancing mitochondrial energy comprising 3 parts adenosine, 0.3 parts sodium mannose phosphate, 1.1 parts mannose, 1 part creatine and 0.6 parts yeast extract.
Example 7
This example provides a composition for enhancing mitochondrial energy comprising 1 part adenosine, 1.6 parts sodium mannose phosphate, 0.4 part mannose, 3 parts creatine, and 0.04 parts yeast extract.
Comparative example 1
This comparative example provides a composition for enhancing mitochondrial energy which differs from example 1 only in that adenosine is not included, its reduced amount is divided into sodium mannose phosphate and mannose in a part ratio, and the remaining components and added amounts are unchanged.
Comparative example 2
This comparative example provides a mitochondrial energy enhancing composition that differs from example 1 only in that sodium mannose phosphate is not included, the reduced amount is apportioned in parts to adenosine and mannose, and the remaining components and amounts added are unchanged.
Comparative example 3
This comparative example provides a mitochondrial energy enhancing composition that differs from example 1 only in that mannose is not included, the reduced amount of which is apportioned in parts to adenosine and sodium mannose phosphate, and the remaining components and amounts of addition are unchanged.
Application example 1
The application example is used for preparing the face-coagulation anti-wrinkle essence cream, and the formula is as follows:
the preparation method comprises the following steps:
(1) Adding deionized water, humectant, skin conditioner and thickener into water phase pot, stirring, heating to 85deg.C, and maintaining for 45min; adding the emulsifier, skin feel regulator and antioxidant into the oil phase pot, stirring and heating to 80 ℃ and preserving heat for 45min;
(2) After the heat preservation is finished, pumping water and an oil pot into an emulsifying pot, homogenizing at 65 ℃ and 800rpm for 20min, cooling to 35 ℃, adding the composition for enhancing mitochondrial energy as described in the embodiment 1, and uniformly mixing to obtain the mitochondrial energy-enhancing composition.
Application examples 2 to 7
The application example provides six kinds of facial-setting anti-wrinkle essence cream, the formula of the cream is different from that of application example 1 only in that the mitochondrial energy-enhancing composition of example 1 is replaced by the mitochondrial energy-enhancing compositions of examples 2-7 with the same additive amount, and other conditions are kept unchanged, and the preparation method refers to application example 1.
Application example 8
The application example provides a facial-setting essence cream, the formula of which is different from that of application example 1 only in that the humectant does not contain butanediol, the decrement of the cream is distributed into dipropylene glycol, hyaluronic acid, sodium hyaluronate and tremella polysaccharide according to the part ratio, and other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 9
The application example provides a facial-setting essence cream, and the formula of the facial-setting essence cream is different from that of application example 1 only in that the humectant does not contain dipropylene glycol, the reduced amount of the moisturizing agent is distributed into butanediol, hyaluronic acid, sodium hyaluronate and tremella polysaccharide according to the part ratio, and other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 10
The application example provides a facial-setting essence cream, and the formula of the facial-setting essence cream is different from that of application example 1 only in that the humectant does not contain hyaluronic acid, the reduced amount of the moisturizing agent is distributed into butanediol, dipropylene glycol, acetylated sodium hyaluronate and tremella polysaccharide according to the part ratio, and other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 11
The application example provides a facial-setting essence cream, and the formula of the facial-setting essence cream is different from that of application example 1 only in that the humectant does not contain sodium hyaluronate, the reduced amount of the moisturizing agent is distributed into butanediol, dipropylene glycol, hyaluronic acid and tremella polysaccharide according to the part ratio, and other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 12
The application example provides a facial-setting essence cream, and the formula of the cream is different from that of application example 1 only in that the humectant does not contain tremella polysaccharide, the reduced amount of the cream is distributed into butanediol, dipropylene glycol, hyaluronic acid and acetylated sodium hyaluronate according to the part ratio, and other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 13
The application example provides a skin-congealing anti-wrinkle essence cream, the formula of which is different from that of application example 1 only in that the skin conditioner does not contain nicotinamide, and the reduced amount of the skin conditioner is distributed into lactobacillus/rice fermentation products, dipalmitoyl hydroxyproline, hydroxypropyl tetrahydropyran triol, palmitoyl tripeptide-5, soluble collagen and tetradecylamino Ding Xianxie amino butyric acid urea trifluoroacetate in parts ratio, and other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 14
The application example provides a skin-congealing anti-wrinkle essence cream, the formula of which is different from that of application example 1 only in that the skin conditioner does not contain lactobacillus/rice fermentation products, and the reduction amount of the skin conditioner is distributed into nicotinamide, dipalmitoyl hydroxyproline, hydroxypropyl tetrahydropyran triol, palmitoyl tripeptide-5, soluble collagen and tetradecylamino Ding Xianxie amino butyric acid urea trifluoroacetate in parts ratio, and the other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 15
The application example provides a skin-setting anti-wrinkle essence cream, the formula of which is different from that of application example 1 only in that the skin conditioner does not contain dipalmitoyl hydroxyproline, and the reduction amount of the skin conditioner is distributed into nicotinamide, lactobacillus/rice fermentation product, hydroxypropyl tetrahydropyran triol, palmitoyl tripeptide-5, soluble collagen and tetradecylamino Ding Xianxie amino butyric acid urea trifluoroacetate in a part ratio, and other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 16
The application example provides a skin-setting anti-wrinkle essence cream, the formula of which is different from that of application example 1 only in that the skin conditioner does not contain hydroxypropyl tetrahydropyran triol, and the reduction amount of the skin conditioner is distributed into nicotinamide, lactobacillus/rice fermentation product, dipalmitoyl hydroxyproline, palmitoyl tripeptide-5, soluble collagen and tetradecylamino Ding Xianxie amino butyric acid urea trifluoroacetate in parts ratio, and the other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 17
The application example provides a skin-setting anti-wrinkle essence cream, the formula of which is different from that of application example 1 only in that the skin conditioner does not contain palmitoyl tripeptide-5, and the reduction amount of the skin conditioner is distributed into nicotinamide, lactobacillus/rice fermentation product, dipalmitoyl hydroxyproline, hydroxypropyl tetrahydropyran triol, soluble collagen and tetradecylamino Ding Xianxie amino butyric acid urea trifluoroacetate in parts ratio, and the other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 18
The application example provides a skin-setting anti-wrinkle essence cream, the formula of which is different from that of application example 1 only in that the skin conditioner does not contain soluble collagen, and the reduced amount of the skin conditioner is distributed into nicotinamide, lactobacillus/rice fermentation product, dipalmitoyl hydroxyproline, hydroxypropyl tetrahydropyran triol, palmitoyl tripeptide-5 and tetradecylamino Ding Xianxie amino butyric acid urea trifluoroacetate in parts ratio, and other components and contents are kept unchanged. The preparation method is described in application example 1.
Application example 19
The application example provides a skin-congealing anti-wrinkle essence cream, the formula of which is different from that of application example 1 only in that the skin conditioner does not contain tetradecylamino Ding Xianxie amino butyric acid urea trifluoroacetate, and the reduced amount of the skin conditioner is distributed into nicotinamide, lactobacillus/rice fermentation product, dipalmitoyl hydroxyproline, hydroxypropyl tetrahydropyran triol, palmitoyl tripeptide-5 and soluble collagen in parts by weight, and the other components and contents are kept unchanged. The preparation method is described in application example 1.
Comparative application examples 1 to 3
Comparative application examples 1 to 3 provided three types of cream for keeping youthful looks and reducing wrinkles, the formulation of which is different from that of application example 1 only in that the composition for enhancing mitochondrial energy of example 1 was replaced with the same amount of the composition for enhancing mitochondrial energy of comparative examples 1 to 3, respectively, and the other ingredients and contents were kept unchanged. The preparation method is described in application example 1.
Comparative application example 4
The present comparative application provides a cream whose formulation differs from application 1 only in that it does not contain the mitochondrial energy enhancing composition of example 1, the other ingredients and amounts remaining unchanged. The preparation method is described in application example 1.
Test example 1
Promoting elastin production experiments
Experiments for promoting elastin formation were performed on the gel Yan Kangzhou essence cream provided in application examples 1 to 7 and the essence cream provided in comparative application examples 1 to 4, as follows:
(1) Human fibroblasts were inoculated on 96-well plates at a density of 20000 cells per well, added with a medium, cultured in an incubator at 37℃for 24 hours, after the cells were attached, replaced with a new medium, and each test sample was added (control sample final concentration was 50 mg/mL) separately, 20mmol/L of PBS solution was used as a blank, and then cultured in an incubator at 37℃for 2 days.
(2) After the completion of the culture, the cells were eluted by using a cell lysate and sonicated. The content of elastin is detected by using a Biocolor elastin detection kit: treating a sample with an elastin precipitant, centrifuging to remove supernatant, adding dye and reaction liquid into the precipitate to react to form elastin-dye complex, centrifuging and washing with PBS solution for three times to remove unbound dye, adding a dye release agent to release the dye in the elastin-dye complex, measuring absorbance of the sample at 513nm by using a spectrophotometer, and calculating the expression level of elastin (the expression level of a blank group is 1) according to an absorbance-dye concentration standard curve;
the specific test results are shown in table 1 below:
TABLE 1
Test sample | Expression level of elastin | Test sample | Expression level of elastin |
Application example 1 | 5.9 | Application example 7 | 5.0 |
Application example 2 | 5.6 | Comparative application example 1 | 3.5 |
Application example 3 | 5.8 | Comparative application example 2 | 2.7 |
Application example 4 | 4.5 | Comparative application example 3 | 3.8 |
Application example 5 | 4.3 | Comparative application example 4 | 2.0 |
Application example 6 | 5.2 |
From the test data in table 1, it is shown that the expression level of elastin of the gel Yan Kangzhou essence cream provided in the application examples 1 to 3 of the present invention is 5.5 or more, while the expression level of elastin of the essence cream of the comparative application example 4 is only 2.0, which indicates that the essence cream of the present invention can stimulate cell growth and increase skin elasticity after adding the composition for enhancing mitochondrial energy, thereby improving skin condition. The expression level of elastin in the essence cream described in comparative application examples 1-3 is only 2.7-3.8, which fully demonstrates that adenosine, sodium mannose phosphate and mannose are matched with each other in the composition for enhancing mitochondrial energy, and the composition has a synergistic effect in promoting elastin expression. From application examples 4 and 5, it is understood that, when either creatine or yeast extract is absent from the composition for enhancing mitochondrial energy, it also has a negative effect on promoting elastin expression by essential creams.
Test example 2 antioxidant and anti-glycation test
(1) Taking 1g of essence cream of application examples 1-19 and comparative application examples 1-4, adding 2mL of absolute ethyl alcohol, adding 2mL of DPPH solution with 60 mu mol/L after complete dissolution, uniformly mixing, standing for 30min, zeroing by the absolute ethyl alcohol, and measuring absorbance at 517nm to be Ai; the same method is to take 2mL absolute ethanol solvent and 2mL DPPH solution to be mixed uniformly, and the absorbance is determined to be Ac; then, 1g of the composition matrix is dissolved, 2mL of absolute ethyl alcohol is added, and 2mL of absolute ethyl alcohol solvent is added to be mixed uniformly, and the absorbance is determined as Aj.
The radical scavenging rate was calculated as follows.
Clearance (%) = [1- (Ai-Aj)/Ac ] ×100%
Wherein Aj reflects the contribution of the sample itself to absorbance; absorbance values after action of Ai sample on DPPH; ac is the absorption of DPPH itself at the measurement wavelength.
The DPPH free radical scavenging rate reflects the antioxidant capacity to a certain extent, and the higher the scavenging rate is, the better the antioxidant degree is, and the better the anti-aging effect is, so the anti-aging effect can be judged through the research of the DPPH free radical scavenging capacity of the composition. The results are shown in table 2 (5 replicates per group of samples, data presented as average).
(2) Anti-glycation effect was tested according to fluorescence of AGEs: the inhibition of AGEs formation by the cream of application examples 1 to 13 and comparative examples 1 to 4 was evaluated using a glucose- β -Lg simulator system. According to fluorescence of AGEs, under the conditions of excitation wavelength of 325nm and emission wavelength of 440nm, using an F-4600 fluorescence spectrometer, measuring fluorescence intensity of fluorescent AGEs after a blank group and a composition test group are added for 7d reaction, and calculating inhibition rate of fluorescent AGEs (wherein each group of test samples is diluted to 5.0wt% by using phosphate buffer solution), wherein the calculation method is as follows:
inhibition (%) = [ (F0-F1)/F0 ] ×100%;
wherein, F0 is the fluorescence intensity of the blank control group; f1—fluorescence intensity of test group;
the specific test results are shown in table 2:
TABLE 2
As shown in Table 2, the gel Yan Kangzhou essence cream prepared by application examples 1-3 has a good DPPH removing effect, the removing rate is more than 86%, the inhibition rate of fluorescent AGEs is more than 91%, and the essence cream disclosed by the invention has the advantages of being matched with each other, synergistic in synergy, good in antioxidation effect, capable of helping cell saccharification reversion and reducing glycosylation reaction. From application examples 13 to 19, it is understood that the combination of the skin conditioning agents in the essence cream of the present invention has an influence on the antioxidant and anti-glycation effects of the essence cream. As is clear from comparative examples application examples 1 to 3, the combination of adenosine, sodium mannose phosphate and mannose in the composition for enhancing mitochondrial energy can significantly enhance the antioxidant and anti-glycation effects of the cream.
Test example 3
Anti-wrinkle effect experiment
Anti-wrinkle effect experiments were performed on the gel Yan Kangzhou essence cream provided in application examples 1 to 7 and the essence cream provided in comparative application examples 1 to 4; the specific test method is as follows:
(1) The experimental object: 110 female volunteers with healthy skin and age of 35-55 years are selected, wherein the proportion of male and female is half, and the women are randomly divided into 11 groups;
(2) Experimental instrument: skin wrinkle tester VL650 from CK company, germany;
(3) The testing method comprises the following steps: measuring the wrinkle depth by adopting a skin wrinkle tester VL650 of German CK company and using silica gel to sleeve the forehead, respectively testing the forehead wrinkles of a tested person, and taking the average value of three test data; the specific use method of the essence cream comprises the steps of cleaning the face at 8 points in the morning, and respectively using 0.5+/-0.05 g of each test sample essence cream on the face after cleaning the face; the face is cleaned at 8 pm, after the face is cleaned, 0.5+/-0.05 g of essence cream of each test sample is respectively used on the face, and the duration of the experimental period is 60 days; finally, the percentage of reduced wrinkle depth after 30 and 60 days of treatment was calculated;
the specific test results are shown in table 3 below:
TABLE 3 Table 3
From the test data in table 3, the reduced percentage of the wrinkle depth of the essence cream provided in application examples 1-3 of the invention reaches more than 23% after 60 days, which fully shows that the components in the essence cream are mutually matched and synergistically enhanced, can effectively resist skin wrinkles and slow down the skin aging process, reduce the generation of static wrinkles, and improve the dynamic wrinkles of the skin by promoting the expression of skin elastin and the proliferation and growth of cells. As is clear from comparative application examples 1 to 3, the composition for enhancing mitochondrial energy had reduced wrinkle-removing effect of essence cream in the absence of any one of adenosine, sodium mannose phosphate and mannose.
Test example 4
Moisture retention performance test:
the gel Yan Kangzhou cream prepared in application examples 1-3 and 8-12 was tested and compared to the skin moisture content of the test subjects before and after use (consistency in use operation), and the test subjects were 80 volunteers, of which women: 56 men, 24, aged 20-40 years, average age 28 years, were randomized into 8 groups of 7 women and 3 men.
The subject cleans the forearms of both hands, sits still for 30min under the set humidity environment, and selects 3X 3cm for each of the left and right forearms of the subject 2 The water content of each experimental part was measured with Corneometer CM825 with the left arm as the test area of the test sample and the symmetric area of the right arm as the blank control, repeated 3 times, and an average value was obtained for recording.
The skin hydration rate was calculated as:
the average skin hydration results of the subjects after 2 hours of use of the samples are shown in table 4:
TABLE 4 Table 4
Group of | Skin hydration rate |
Application example 1 | 44.5% |
Application example 2 | 43.7% |
Application example 3 | 42.9% |
Application example 8 | 35.6% |
Application example 9 | 32.4% |
Application example 10 | 36.6% |
Application example 11 | 38.3% |
Application example 12 | 36.5% |
As can be seen from the data in table 4: the gel Yan Kangzhou essence cream has a stronger moisturizing effect; the five components of butanediol, dipropylene glycol, hyaluronic acid, acetylated sodium hyaluronate and tremella polysaccharide in the humectant have a certain synergistic effect on the effects, and the five components are indispensable.
Test example 5: erythrocyte hemolysis experiment
The erythrocyte hemolysis test (Red blood cell haemolysis test, RBC) is one of the alternative methods for the rabbit eye-stimulating test, and the basic principle is to evaluate the damage of chemicals to eye tissue cells by measuring the amount of cellular hemoglobin and the degree of denaturation. RBC experiments can be used to evaluate eye irritation of cosmetics.
Erythrocyte hemolysis experiments were performed on the gel Yan Kangzhou essence cream prepared in application examples 1-19. RBC experiment test method and judgment standard of European alternative method verification center are shown in Table 5, wherein HD 50 At a sample concentration of 50% when erythrocyte hemolysis occurs, DI is the protein denaturation index, and L/D is HD 50 Ratio to DI.
TABLE 5
The results of the irritation of each of the samples to be tested prepared in application examples 1 to 19 are shown in Table 6.
TABLE 6
As can be seen from the sample irritation results in Table 6, the irritation of the gel Yan Kangzhou essence cream prepared in application examples 1-19 of the invention is classified as non-irritating, which indicates that each component in the essence cream of the invention has the characteristics of mildness and non-irritation.
The applicant states that the present invention is illustrated by the above examples as a composition for enhancing mitochondrial energy and its use, but the invention is not limited to, i.e. it is not meant that the invention must be practiced in dependence upon the above examples. It should be apparent to those skilled in the art that any modification of the present invention, equivalent substitution of raw materials for the product of the present invention, addition of auxiliary components, selection of specific modes, etc., falls within the scope of the present invention and the scope of disclosure.
The preferred embodiments of the present invention have been described in detail above, but the present invention is not limited to the specific details of the above embodiments, and various simple modifications can be made to the technical solution of the present invention within the scope of the technical concept of the present invention, and all the simple modifications belong to the protection scope of the present invention.
In addition, the specific features described in the above embodiments may be combined in any suitable manner, and in order to avoid unnecessary repetition, various possible combinations are not described further.
Claims (10)
1. A composition for enhancing mitochondrial energy, wherein the composition for enhancing mitochondrial energy comprises adenosine, sodium mannose phosphate, and mannose.
2. The mitochondrial energy enhancing composition of claim 1 wherein the mass ratio of adenosine, sodium mannose phosphate, and mannose is (3-5): 1-3): 1-2.
3. The mitochondrial energy enhancing composition of claim 1 or 2, wherein the mitochondrial energy enhancing composition further comprises creatine and/or yeast extract;
preferably, the mitochondrial energy enhancing composition comprises adenosine, sodium mannose phosphate, mannose, creatine and yeast extract;
preferably, the mass ratio of adenosine, sodium mannose phosphate, mannose, creatine and yeast extract is (3-5): 1-3): 1-2): 3-5): 0.1-1.
4. Use of a composition for enhancing mitochondrial energy according to any one of claims 1-3 in cosmetics.
5. The use according to claim 4, wherein the cosmetic comprises a cream, lotion, emulsion, face cream or mask;
preferably, the composition for enhancing mitochondrial energy comprises 1-15% by mass of the cosmetic.
6. A facial and anti-wrinkle essence cream comprising the composition for enhancing mitochondrial energy of any one of claims 1 to 3, a humectant, a thickener, a skin conditioner, an antioxidant, an emulsifier, a skin feel modifier, and deionized water.
7. The gel Yan Kangzhou essential cream of claim 6, wherein the gel Yan Kangzhou essential cream comprises, in parts by weight, 1-15 parts of the composition for enhancing mitochondrial energy of any one of claims 1-3, 1-20 parts of a humectant, 0.1-1 part of a thickener, 5-10 parts of a skin conditioner, 0.1-1 part of an antioxidant, 1-10 parts of an emulsifier, 1-10 parts of a skin feel modifier, and 1-90 parts of deionized water.
8. The gel Yan Kangzhou essence cream of claim 6 or 7, wherein the humectant comprises any one or a combination of at least two of glycerin, butylene glycol, panthenol, hyaluronic acid, sodium hyaluronate, dipropylene glycol, or tremella polysaccharide;
preferably, the humectant is a combination of butylene glycol, dipropylene glycol, hyaluronic acid, sodium hyaluronate and tremella polysaccharide;
preferably, the thickener comprises any one or a combination of at least two of acrylic acid (esters) and C10-30 alkanol acrylate cross-linked polymers, cetyl alcohol or stearyl alcohol;
preferably, the antioxidant comprises any one or a combination of at least two of retinol palmitate, p-hydroxyacetophenone or tocopheryl acetate;
preferably, the emulsifier comprises any one or a combination of at least two of hydrogenated lecithin, phytosterols, C14-22 alcohol/C12-20 alkyl glucoside or ammonium acryloyldimethyl taurate/VP copolymer;
preferably, the skin feel modifier comprises any one or a combination of at least two of sodium polyacryl dimethyl taurate, polyisobutylene, PEG-7 trimethylol propyl coco ether, cetyl ethyl hexanoate, diisostearyl malate, polydimethylsiloxane, rice germ oil, aluminum starch octenyl succinate, squalane, or jojoba seed oil;
preferably, the skin conditioning agent comprises any one or a combination of at least two of soluble collagen, lactobacillus/rice fermentation product, dipalmitoyl hydroxyproline, dipotassium glycyrrhizinate, nicotinamide, beta-glucan, hydroxypropyl tetrahydropyran triol, palmitoyl tripeptide-5, yeast lysate, citrus peel extract, chlorella/Bai Yushan soy protein fermentation product, hydrolyzed royal jelly protein, tetradecylamino Ding Xianxie amino amidobutyrate urea trifluoroacetate, soluble collagen, saffron extract or sweet orange extract;
preferably, the skin conditioning agent is a combination of niacinamide, lactobacillus/rice fermentation product, dipalmitoyl hydroxyproline, hydroxypropyl tetrahydropyran triol, palmitoyl tripeptide-5, soluble collagen, tetradecylamino Ding Xianxie amino butyric acid urea trifluoroacetate;
preferably, the gel Yan Kangzhou essence cream further comprises any one or a combination of at least two of a pH regulator, a preservative or a fragrance.
9. A method of preparing a gel Yan Kangzhou essence cream according to any one of claims 6 to 8, comprising:
(1) Adding deionized water, a humectant and a thickener into a water phase pot, stirring, heating and preserving heat; adding the emulsifier, the skin feel regulator and the antioxidant into an oil phase pot, stirring, heating and preserving heat;
(2) After the heat preservation is finished, pumping water and an oil pot into an emulsifying pot, homogenizing, stirring and cooling under vacuum, adding the composition for enhancing mitochondrial energy and the skin conditioning agent according to any one of claims 1-3, and uniformly mixing.
10. The method for preparing the essence cream of congee Yan Kangzhou according to claim 9, wherein the temperature of the heat preservation in the step (1) is respectively and independently 80-85 ℃, and the time of the heat preservation is respectively and independently 10-20min;
preferably, the homogenizing temperature in the step (2) is 78-85 ℃, the homogenizing time is 5-10min, the homogenizing rotating speed is 3000-5000rpm, and the stirring speed is 20-30rpm;
preferably, the temperature in the step (2) is reduced to 30-40 ℃;
preferably, step (2) further comprises adding any one or a combination of at least two of a pH adjuster, a fragrance, or a preservative.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310830062.4A CN116687781A (en) | 2023-07-07 | 2023-07-07 | Composition for enhancing mitochondrial energy and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310830062.4A CN116687781A (en) | 2023-07-07 | 2023-07-07 | Composition for enhancing mitochondrial energy and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116687781A true CN116687781A (en) | 2023-09-05 |
Family
ID=87839211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310830062.4A Pending CN116687781A (en) | 2023-07-07 | 2023-07-07 | Composition for enhancing mitochondrial energy and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116687781A (en) |
-
2023
- 2023-07-07 CN CN202310830062.4A patent/CN116687781A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112494406A (en) | Whitening and freckle-removing cosmetic and preparation method thereof | |
FR2770776A1 (en) | USES OF D-XYLOSE AND ITS ESTERS TO IMPROVE THE FUNCTIONALITY OF SKIN CELLS | |
CN110115704B (en) | Enzyme composition and application thereof in cosmetics with whitening function | |
CN108261376B (en) | Three-dimensional moisturizing factor | |
CN113081890A (en) | Essence with anti-sugar and anti-oxidation functions and preparation method thereof | |
CN109350579B (en) | Whitening cosmetic additive, whitening skin-refreshing lotion and preparation method thereof | |
KR20150120426A (en) | Cosmetic composition containing a brown alga extract, a yeast extract and ascorbic acid | |
CN113712874A (en) | Skin care product containing water-soluble silicon element and preparation method and application thereof | |
CN111603404B (en) | Skin care essence containing cell extracting solution and preparation method thereof | |
CN112773761B (en) | Cosmetic composition, essence and preparation method thereof | |
CN113368003A (en) | Composition with overnight muscle repairing effect and preparation method and application thereof | |
CN113633573A (en) | Whitening and spot-fading essence and preparation method thereof | |
CN113633575A (en) | Skin color brightening composition and preparation method of essence thereof | |
CN115518012B (en) | Composition with effects of inhibiting melanin protein and improving black eye and eye pouch and application thereof | |
CN116440048A (en) | Composite retinol composition and preparation method and application thereof | |
TW202106323A (en) | Use ofrosmarinus officinaliscallus extract for manufacturing composition inhibiting skin aging and a culture medium for inducingrosmarinus officinaliscallus | |
CN111358748A (en) | Mask essence containing date palm seed extract and preparation method thereof | |
KR102381645B1 (en) | Cosmetic Composition Comprising Poria cocos Fermentation Extract | |
CN116687781A (en) | Composition for enhancing mitochondrial energy and application thereof | |
CN115919686A (en) | Skin soothing lotion for enhancing skin barrier and preparation method thereof | |
CN115414289A (en) | Cordyceps flower cosmetics and preparation method thereof | |
CN115040448A (en) | Skin care product with enhanced anti-aging effect and preparation method thereof | |
CN108685729B (en) | Face cream and preparation method thereof | |
CN111743798A (en) | Multi-effect anti-aging skin care product and preparation method thereof | |
CN113384483A (en) | Composition for improving skin elasticity and delaying aging and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |